These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4542057)

  • 1. The estrogenic potency of ethinylestradiol and mestranol--a comparative study.
    Schwartz U; Hammerstein J
    Acta Endocrinol Suppl (Copenh); 1973; 173():118. PubMed ID: 4542057
    [No Abstract]   [Full Text] [Related]  

  • 2. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.
    Schwartz U; Hammerstein J
    Acta Endocrinol (Copenh); 1974 May; 76(1):159-71. PubMed ID: 4406579
    [No Abstract]   [Full Text] [Related]  

  • 3. An in vivo system in man for quantitation of estrogenicity. II. Pharmacologic changes in binding capacity of serum corticosteroid-binding globulin induced by conjugated estrogens, mestranol, and ethinyl estradiol.
    Moore DE; Kawagoe S; Davajan V; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1978 Feb; 130(4):482-6. PubMed ID: 204191
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1977 Nov; 28(11):1182-90. PubMed ID: 411689
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proceedings: Estrogen over or undersupply in hormonal contraception?].
    Schwartz U; Hammerstein J
    Arch Gynakol; 1973 Sep; 214(1):255-6. PubMed ID: 4801442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormonal contraceptives in female rowers].
    Lisý Z
    Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modifications in the menstrual pattern during use of hormonal contraceptives].
    de Sampaio LF; Novo NF; de Paiva ER
    Matern Infanc (Sao Paulo); 1974; 33(3):367-70. PubMed ID: 4466962
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenocortical function of patients using oral contraceptives.
    Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
    Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of synthetic estrogens on the metabolic clearance and production rates of estrone and estradiol.
    Longcope C; Watson D; Williams KI
    Steroids; 1974 Jul; 24(1):15-30. PubMed ID: 4843804
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen potencies of three new low-dose oral contraceptives.
    Dickey RP; Chihal HJ; Peppler RD
    Am J Obstet Gynecol; 1976 Aug; 125(7):976-9. PubMed ID: 941952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The behavior of the gonadotropins FSH and LH during and after treatment with estrogenic and progestational drugs].
    Ramadori P; Lirosi G
    Patol Clin Ostet Ginecol; 1973; 1(1):26-34. PubMed ID: 4143256
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha fetoprotein levels in women taking oral contraceptives.
    Seppälä M
    Int J Fertil; 1973; 18(4):206-8. PubMed ID: 4359688
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of various steroids on the vaginal histology in the rat.
    Jones RC; Edgren RA
    Fertil Steril; 1973 Apr; 24(4):284-91. PubMed ID: 4694503
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.